Wow, I did't expect these numbers especially when they were
Wow, I did't expect these numbers especially when they were saying that sales were above expectations. It makes sense why they were not forthcoming with sales numbers or any news on it because they weren't the best...had a feeling about that. Sort of bummed out since I was very optimistic in better sales figures. The gross profit numbers are just terrible, I know they are trying to clean up but man that sucks. The good thing about the report was the lawsuits are all going our way and that's being cleaned up well. Our expenses are off the charts again which I figured they would be with the launch of Hempd, but still shocked that they were not as popular as portrayed. I also noticed that they have severed contracts with Advisory Board and eliminated the Advisory Board and the Board of Directions...found that a bit interesting. Overall, not too happy and it's sad to say that only the Mexican deal can really bring us back to life. I'll be totally honest to say that if that deal falls through, I don't think RMHB will survive that blow. I think the surprise podcast was to soften the blow of the 10-Q. Hopefully we get some type of news tomorrow otherwise I think this stock is going to take a pretty decent hit tomorrow and Wednesday. Don't get me wrong, I still have faith in this stock and if it does go to half a penny I think I will get more shares, but I hope to God I'm wrong.
4
2
Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...
Continue Reading
BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...
Continue Reading
Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...
Continue Reading
Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...
Continue Reading
Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...
Continue Reading
